Pricing Log in Create free account

Larimar Therapeutics, Inc. (LRMR) vs Pyxis Oncology, Inc. (PYXS)

Larimar Therapeutics, Inc. and Pyxis Oncology, Inc. are both Biotechnology companies. Larimar Therapeutics, Inc. and Pyxis Oncology, Inc. are of similar size ($215.3M and $206.7M). Across the 8 metrics below, Larimar Therapeutics, Inc. leads on 4 and Pyxis Oncology, Inc. on 4.

Valuation

Metric LRMR PYXS Biotechnology median
P/E n/m n/m 8.42
P/S n/m n/m 10.01
P/B 1.62 10.07 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales n/m n/m 9.41
Earnings yield (97.99%) (78.33%) (31.85%)
Free cash flow yield (75.51%) (58.96%) (24.58%)

Profitability

Metric LRMR PYXS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.41%) (179.10%) (56.36%)
Return on assets (108.53%) (99.62%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LRMR PYXS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (71.97%) 3.03% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LRMR PYXS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.70 1.34 4.72
Net debt to EBITDA 0.79 0.82 0.96

Dividend

Metric LRMR PYXS Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric LRMR PYXS Biotechnology median
Market cap 206.73m 215.25m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack